Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Hope for non-animal testing

Skin model proves a successful testing method

Researchers have found that a model replicating the traits of human skin could provide a replacement for animals in future clinical research.

A study taking place at the Flemish Institute for Technological Research (VITO) in Belgium, found that a skin sensitisation assay can successfully identify chemicals causing human allergic responses.

The research team used a three-dimensional, human-derived skin model, which replicates key traits of normal human skin.

This could replace the use of guinea pigs or mice, which are injected with or have substances applied to their skin to determine allergic reactions.

Researchers found that the model accurately predicated each chemical's ability to cause an allergic response for all of the compounds tested.

These findings support those reported by Michigan-based research organisation, CeeTox, who created the skin sensitisation assay.

Further validation studies will be carried out, and the results are to be submitted to the European Centre for the Validation of Alternative Methods, which officially approves the methods of chemical testing required by law.

The announcement follows a recent ban in Europe on the sale of cosmetics that have been tested on animals.

Related News
Committee to advise on research animals
Animals for scientific procedures consultation

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.